Carbon monoxide inhalation ameliorates conditions of lung grafts from rat brain death donors

Chinese Medical Journal

Volumn 121, Issue 15, 2008, Pages 1411-1419

  Zhou, Hua Cheng ^a   Ding, Wen Gang ^a   Cui, Xiao Guang ^a   Pan, Peng ^a   Zhang, Bing ^a   Li, Wen Zhi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Brain death; Carbon monoxide; Lung transplantation; Reperfusion injury

Indexed keywords

CARBON MONOXIDE; CASPASE 3; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BALLOON CATHETER; BRAIN DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INHALATION; LUNG INJURY; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MALE; NONHUMAN; ORGAN DONOR; PROTECTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TISSUE GRAFT;

EID: 51349130085     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200808010-00015     Document Type: Article

References (43)

1. Bertolotti A, Gomez C, Lascano E, Negroni J, Cuniberti L, Yannarelli G, et al. Effect of preservation solution on graft viability in single-lung transplantation from heart-beating donors in pigs. Transplant Proc 2007; 39: 355-357.
2. Okada Y, Kondo T. Impact of lung preservation solutions, Euro-Collins vs low-potassium dextran. on early graft function: a review of five clinical studies. Ann Thorac Cardiovasc Surg 2006; 12: 10-14.
3. Snell GI, Westall GP. Immunosuppression for lung transplantation evidence to date Drugs 2007: 67: 1531-1539.
4. Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006, 354: 141-150.
5. van der Kaaij NP, Haitsma JJ, Kluin J, Lambrecht BN, Lachmann B, de Bruin RW, et al. Surfactant pretreatment ameliorates ischemila-reperfusion injury of the lung. Eur J Cardiothorac Surg 2005; 27: 774-782.
6. Mascia L, Bosma K, Pasero D, Galli T, Cortese G, Donadio P, et al, Ventilatory and hemodynamic management of potential organ donors: an observational survey. Crit Care Med 2006; 34: 321-327.
7. Garrity ER, Moore J, Mulligan MS, Shearon TH, Zucker MJ, Murray S. Heart and lung transplantation in the United States, 1996-2005. Am J Transplant 2007; 7: 1390-1403.
8. Avlonitis VS, Wigfield CH, Kirby JA, Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005; 5: 684-693.
9. van Der Hoeven JA, Ter Horst GJ, Molema G, de Vos P, Girbes AR, Postema F, et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 2000; 232: 804-813.
10. Hoeger S, Gottmann U, Liu Z, Schnuelle P, Birck R, Braun C, et al. Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation. Transpl Int 2007; 20: 790-799.
11. Nijboer WN, Schuurs TA, van der Hoeven JA, Leuvenink HG, van der Heide JJ, van Goor H, et al. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplant Proc 2005; 37: 367-369.
12. Matuschak GM. Optimizing ventilatory support of the potential organ donor during evolving brain death: maximizing lung availability for transplantation. Crit Care Med 2006; 34: 548-549.
13. Ghosh S, Bethune DW, Hardy I, Kneeshaw J, Latimer RD, Oduro A. Management of donors for heart and heart-lung transplantation. Anaesthesia 1990; 45: 672-675.
14. Egan TM, Hoffmann SC, Sevala M, Sadoff JD, Schlidt SA. Nitroglycerin reperfusion reduces ischemia-reperfusion injury in non-heart-beating donor lungs. J Heart Lung Transplant 2006; 25: 110-119.
15. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart lung Transplant 1998; 17: 423-429.
16. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, Choi AM. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 2007; 282: 1718-1726.
17. Ryter SW, Choi AM. Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models. Novartis Found Symp 2007; 280: 165-175; discussion 175-181.
18. Contreras JL, Eckstein C, Smyth CA, Sellers MT, Vilatoba M, Bilbao G, et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003: 52: 2935-2942.
19. Mizobuchi T, Sekine Y, Yasufuku K, Fujisawa T, Wilkes DS. Comparison of surgical procedures for vascular and airway anastomoses that utilize a modified non-suture external cuff technique for experimental lung transplantation in rats. J Heart Lung Transplant 2004; 23: 889-893.
20. Pirat A, Zeyneloglu P, Aldemir D, Yucel M, Ozen O, Candan S, et al. Pretreatment with simvastatin reduces lung injury related to intestinal ischemia-reperfusion in rats. Anesth Analg 2006; 102: 225-232.
21. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000; 89: 2637-2645.
22. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, et al. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 2003; 163: 231-242.
23. Sarady JK, Zuckerbraun BS, Bilban M, Wagner O, Usheva A, Liu F, et al. Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. Faseb J 2004; 18: 854-856.
24. Weill D. Donor criteria in lung transplantation: an issue revisited. Chest 2002; 121: 2029-2031.
25. Neyrinck AP, Van De Wauwer C, Geudens N, Rega FR, Verleden GM, Wouters P, et al. Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur J Cardiothorac Surg 2006; 30: 628-636.
26. Avlonitis VS, Wigfield CH, Golledge HD, Kirby JA, Dark JH. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 83-90.
27. Zweers N, Petersen AH, van der Hoeven JA, de Haan A, Ploeg RJ, de Leij LF, et al. Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation 2004; 78: 1251-1258.
28. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T, et al. Suppressiorr of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003; 278: 36993-36998.
29. Wang H, Lee SS, Gao W, Czismadia E, McDaid J, Ollinger R, et al, Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 2005; 54: 1400-1406.
30. Luckraz H, Tsui SS, Parameshwar J, Wallwork J, Large SR. Improved outcome with organs from carbon monoxide poisoned donors for intrathoracic transplantation. Ann Thorac Surg 2001; 72: 709-713.
31. Shennib H, Adoumie R, Fraser R. Successful transplantation of a lung allograft from a carbon monoxide-poisoning victim. J Heart Lung Transplant 1992; 11: 68-71.
32. Ross SD, Tribble CG, Gaughen JR Jr, Shockey KS, Parrino PE, Kron IL. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg 1999; 67: 1428-1433.
33. Lu YT, Chen PG, Liu SF. Time course of lung ischemia-reperfusion-induced ICAM-1 expression and its role in ischemia-reperfusion lung injury. J Appl Physiol 2002; 93: 620-628.
34. Okutan H, Savas C, Delibas N. The antioxidant effect of melatonin in lung injury aller aortic occlusion-reperfusion interact Cardiovasc Thorac Surg 2004; 3: 519-522.
35. Fischer S, Maclean AA, Liu M, Cardella JA, Slutsky AS, Suga M, et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 2000; 162: 1932-1939.
36. Stammberger U, Gaspert A, Hillinger S, Vogt P, Odermatt B, Weder W, et al. Apoptosis induced by ischemia and reperfusion in experimental lung transplantation. Ann Thorac Surg 2000; 69: 1532-1536.
37. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, et al. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 2003; 278: 1248-1258.
38. Ryter SW, Morse D, Choi AM. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am J Respir Cell Moll Biol 2007; 36: 175-182.
39. Kohmoto J, Nakao A, Kaizu T, Tsung A, Ikeda A, Tomiyama K, et al. Low-dose carbon monoxide inhalation prevents ischemia/reperfusion injury of transplanted rat lung grafts. Surgery 2006; 140: 179-185.
40. Zhang Y, Gu EW, Zhang J, Chen ZW. Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning. Chin Med J 2007; 120: 777-781.
41. Ryter SW, Otterbein LE, Morse D, Choi AM. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 2002; 234-235: 249-263.
42. Kohmoto J, Nakao A, Stolz DB, Kaizu T, Tsang A, Ikeda A, et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant 2007; 7: 2279-2290.
43. Nakao A, Choi AM, Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med 2006; 10: 650-671.